Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.03.9923.1222
Address
Level 10 99 Queen Street Melbourne, Victoria (VIC) 3000
Description
Opyl Ltd. is an information technology company, which engages in the development of digital tools that improve the healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of clinical research process. Its services Opin-Clinical Trial Recuitment platform created by Opyl that leverages social media, search engine optimization technologies, and emerging artificial intelligence science, matching patients directly to clinical trials. The company was founded by Marc Angelone and Noah Abelson-Gertleron on January 17, 1994 and is headquartered in St. Kilda, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.05
Trade Value (12mth)
AU$1,149.00
1 week
0%
1 month
3.85%
YTD
-6.9%
1 year
-43.7%
All time high
125919.00
EPS 3 yr Growth
-69.500%
EBITDA Margin
-373.10%
Operating Cashflow
-$1m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-1,097.20
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
119m
HALO Sector
Technology
Next Company Report Date
27-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
24 July 24 |
OPL signs MOU for EMEA & US Expansion
×
OPL signs MOU for EMEA & US Expansion |
11 July 24 |
Change of Director's Interest Notice - D Rasheed
×
Change of Director's Interest Notice - D Rasheed |
08 July 24 |
Opyl Partners with L39 Capital to Launch AI Biotech Fund
×
Opyl Partners with L39 Capital to Launch AI Biotech Fund |
17 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
17 June 24 |
Change in substantial holding
×
Change in substantial holding |
14 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
14 June 24 |
Change in substantial holding
×
Change in substantial holding |
06 June 24 |
Opyl Announces First Trial Gen Revenue & Customer
×
Opyl Announces First Trial Gen Revenue & Customer |
05 June 24 |
Change of Director's Interest Notice - D Rasheed
×
Change of Director's Interest Notice - D Rasheed |
05 June 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
05 June 24 |
Change in substantial holding
×
Change in substantial holding |
04 June 24 |
Application for quotation of securities - OPL
×
Application for quotation of securities - OPL |
04 June 24 |
Cleansing notice
×
Cleansing notice |
04 June 24 |
Notification regarding unquoted securities - OPL
×
Notification regarding unquoted securities - OPL |
03 June 24 |
Opyl Announces Successful Transition of Opin to Trial Screen
×
Opyl Announces Successful Transition of Opin to Trial Screen |
03 June 24 |
Opyl Announces Launch of 'Trial Gen' by TrialKey
×
Opyl Announces Launch of 'Trial Gen' by TrialKey |
31 May 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
27 May 24 |
Results of Meeting
×
Results of Meeting |
23 May 24 |
Change of Director's Interest Notice - A Guoga
×
Change of Director's Interest Notice - A Guoga |
14 May 24 |
Notification of cessation of securities - OPL
×
Notification of cessation of securities - OPL |
07 May 24 |
Investor Presentation
×
Investor Presentation |
02 May 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
02 May 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
30 April 24 |
Opyl - Business Update & Appendix 4C
×
Opyl - Business Update & Appendix 4C |
30 April 24 |
Investor Webinar
×
Investor Webinar |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.